The Oxford AHSN is making a difference to the delivery of healthcare in many ways, according to Oxford Health Chief Executive Stuart Bell.
He said the AHSN has had a ‘catalytic effect’, imparting valuable influence, knowledge and expertise and ‘pulling together collective endeavour’ across the NHS.
Speaking at an Oxford AHSN/Oxford Health event, he said: “What the AHSN has created is a real asset in this area. There’s a huge amount of activity going on. We are in a good position to build sustainability and transformation plans because of the work done by the AHSN over the past three years, particularly in clinical networks.
“They are national leaders in early intervention in psychosis and anxiety and depression. And there is an impact well beyond the Oxford AHSN area.”
Stuart Bell was speaking at the sixth of seven Oxford AHSN events showcasing the benefits to patients of collaborations between industry, universities and the NHS.
Around 40 people attended the showcase at the Warneford Hospital on 25 May.
Dr Paul Durrands, Chief Operating Officer at the Oxford AHSN, gave an overview of the depth and breadth of collaboration across the Oxford AHSN region.
This was demonstrated in more detailed presentations covering dementia, early intervention in psychosis, anxiety and depression and patient safety on mental health wards.
There were also updates on the Oxford Academic Health Science Centre and a bid for a new Biomedical Research Centre.